125 related articles for article (PubMed ID: 38697202)
1. Quality of care measurement for patients with ovarian cancer in Japan.
Kakuwa T; Watanabe T; Niino M; Kawata A; Satoh T; Matsumura N; Yokoyama Y; Kawana K; Hirashima Y; Kyo S; Yasuda M; Harano K; Machida H; Tokunaga H; Kaneuchi M; Tabata T; Kobayashi Y; Nagase S; Katabuchi H; Mikami M; Yamamoto Y; Rikitake R; Ichinose Y; Higashi T
J Obstet Gynaecol Res; 2024 May; ():. PubMed ID: 38697202
[TBL] [Abstract][Full Text] [Related]
2. Quality indicators for cervical cancer care in Japan.
Watanabe T; Mikami M; Katabuchi H; Kato S; Kaneuchi M; Takahashi M; Nakai H; Nagase S; Niikura H; Mandai M; Hirashima Y; Yanai H; Yamagami W; Kamitani S; Higashi T
J Gynecol Oncol; 2018 Nov; 29(6):e83. PubMed ID: 30207093
[TBL] [Abstract][Full Text] [Related]
3. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
Bristow RE; Chang J; Ziogas A; Anton-Culver H
Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
[TBL] [Abstract][Full Text] [Related]
4. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
[TBL] [Abstract][Full Text] [Related]
5. Monitoring and evaluating the quality of cancer care in Japan using administrative claims data.
Iwamoto M; Nakamura F; Higashi T
Cancer Sci; 2016 Jan; 107(1):68-75. PubMed ID: 26495806
[TBL] [Abstract][Full Text] [Related]
6. Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).
Jochum F; De Rozario T; Lecointre L; Faller E; Boisrame T; Dabi Y; Lavoué V; Coutant C; Touboul C; Bolze PA; Bricou A; Canlorbe G; Collinet P; Huchon C; Bendifallah S; Ouldamer L; Mezzadri M; Querleu D; Akladios C
Int J Gynecol Cancer; 2021 Nov; 31(11):1443-1452. PubMed ID: 34607855
[TBL] [Abstract][Full Text] [Related]
7. Developing quality indicators for cancer hospitals in China: a national modified Delphi process.
Liu M; Yu Q; Liu Y
BMJ Open; 2024 Apr; 14(4):e082930. PubMed ID: 38594187
[TBL] [Abstract][Full Text] [Related]
8. Updating quality indicators for low-risk labour care in Japan using current clinical practice guidelines: a modified Delphi method.
Ueda K; Kaso M; Ohtera S; Nakayama T
BMJ Open; 2019 Feb; 9(2):e023595. PubMed ID: 30819701
[TBL] [Abstract][Full Text] [Related]
9. Development of Quality Indicators of Stroke Centers and Feasibility of Their Measurement Using a Nationwide Insurance Claims Database in Japan ― J-ASPECT Study ―.
Nishimura A; Nishimura K; Onozuka D; Matsuo R; Kada A; Kamitani S; Higashi T; Ogasawara K; Shimodozono M; Harada M; Hashimoto Y; Hirano T; Hoshino H; Itabashi R; Itoh Y; Iwama T; Kohriyama T; Matsumaru Y; Osato T; Sasaki M; Shiokawa Y; Shimizu H; Takekawa H; Nishi T; Uno M; Yagita Y; Ido K; Kurogi A; Kurogi R; Arimura K; Ren N; Hagihara A; Takizawa S; Arai H; Kitazono T; Miyamoto S; Minematsu K; Iihara K;
Circ J; 2019 Oct; 83(11):2292-2302. PubMed ID: 31554766
[TBL] [Abstract][Full Text] [Related]
10. "Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".
Gernier F; Ahmed-Lecheheb D; Pautier P; Floquet A; Nadeau C; Frank S; Alexandre J; Selle F; Berton-Rigaud D; Kalbacher E; Orfeuvre H; Lortholary A; Augereau P; Labombarda F; Perrier L; Grellard JM; Licaj I; Clarisse B; Savoye AM; Bourien H; De La Motte Rouge T; Kurtz JE; Kerdja K; Lelaidier A; Charreton A; Ray-Coquard I; Joly F
BMC Cancer; 2021 Oct; 21(1):1147. PubMed ID: 34702204
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Selection of key recommendations for the management of women with endometriosis by an international panel of patients and professionals.
Schleedoorn MJ; Nelen WL; Dunselman GA; Vermeulen N;
Hum Reprod; 2016 Jun; 31(6):1208-18. PubMed ID: 27112700
[TBL] [Abstract][Full Text] [Related]
13. Optimal chemotherapy treatment for women with recurrent ovarian cancer.
Fung-Kee-Fung M; Oliver T; Elit L; Oza A; Hirte HW; Bryson P
Curr Oncol; 2007 Oct; 14(5):195-208. PubMed ID: 17938703
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
[TBL] [Abstract][Full Text] [Related]
15. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
16. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators.
Bilimoria KY; Bentrem DJ; Lillemoe KD; Talamonti MS; Ko CY;
J Natl Cancer Inst; 2009 Jun; 101(12):848-59. PubMed ID: 19509366
[TBL] [Abstract][Full Text] [Related]
17. ESHRE guideline: female fertility preservation.
; Anderson RA; Amant F; Braat D; D'Angelo A; Chuva de Sousa Lopes SM; Demeestere I; Dwek S; Frith L; Lambertini M; Maslin C; Moura-Ramos M; Nogueira D; Rodriguez-Wallberg K; Vermeulen N
Hum Reprod Open; 2020; 2020(4):hoaa052. PubMed ID: 33225079
[TBL] [Abstract][Full Text] [Related]
18. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
[TBL] [Abstract][Full Text] [Related]
19. Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey study.
Bergamini A; Ramaswami R; Froeling F; Papanastasopoulos P; Short D; Aguiar X; Savage PM; Sarwar N; Kaur B; Saso S; Fotopoulou C; Sharma A; Rustin GJS; Seckl M
Int J Gynecol Cancer; 2023 Nov; 33(11):1750-1756. PubMed ID: 37931975
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
